2m 2m 2m 2m 2m 2m 2m
CAPSOVISION (CV)
NASDAQ
$6.60-$0.005 (-0.08%)
Price as of Sep 11, 2026 7:30 PM EDT- $330.3MMarket Cap
- 60.19%1-Year Change
- Medical DevicesIndustry
CAPSOVISION (CV)
$6.60-$0.005 (-0.08%)
CV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.60 | ||
Change | +$0.08 (+1.23%) | ||
Open | $6.54 | ||
High | $6.89 | ||
Low | $6.50 | ||
Previous Close | $6.52 | ||
Volume | 207,060 | ||
30-Day Average Volume | 108,802 | ||
1-Week Change | 10.18% | ||
1-Month Change | 0.00% | ||
1-Year Change | 60.19% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 50.0M | ||
Total Assets | $18.6M | ||
Market Cap | $330.3M | ||
Enterprise Value | $321.2M | ||
Period: QTR TTM FY | |||
Revenue | $3.6M | ||
Net Income | -$7.5M | ||
Free Cash Flow | -$8.4M | ||
EBIT | -$7.5M | ||
EBITDA | -$7.4M | ||
Net Working Capital | $12.1M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 88 | ||
P/B | 25 | ||
P/E | -44 | ||
PEG | N/A | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -39 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 05/02/2012 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue